ROSEN, A TOP-RANKING LAW FIRM, Encourages Dentsply Sirona Inc. Investors with losses in excess of $100K to secure an advisory before January 27 Important Deadline in the Securities Class By Investing.com

New York, New York — (Newsfile Corp. – January 19, 2025) – FOR WHAT: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025, the deadline of the main actor.

SO WHAT: If you purchased Dentsply Sirona common stock during the Class Period, you may be entitled to compensation without payment of any out-of-pocket expenses or expenses through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you want to serve as the main actor, you must move the Court no later than January 27, 2025. A principal plaintiff is a representative party who acts on behalf of the other members of the class in conducting the litigation.

Why ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often, companies issuing notices do not have comparable experience, resources, or significant peer recognition. Many of these firms do not actually litigate securities class actions, but are simply intermediaries who refer clients or partners with law firms that actually litigate cases. Be cautious in selecting counsel. The Rosen Law Firm represents investors around the globe, focusing its practice on securities class actions and shareholder derivative litigation. Rosen Law Firm has obtained the largest securities class action settlement against a Chinese Company at the time. Rosen Law Firm was ranked No. 1 by ISS Securities Class Action (WA:) Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured more than $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 Titan of Plaintiffs’ Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, during the Class Period, the defendants made false and/or misleading statements and/or failed to disclose material facts necessary to make the statements made, given the circumstances in which they were made, not false and misleading. Indeed, Byte’s aligners have been causing serious injuries to patients since at least May 2021, as revealed in backlog injury reports that Dentsply Sirona submitted to the Food and Drug Administration (FDA) of the United States in 2024. the problem was that customer service employees and supervising dentists were incentivized to enroll contraindicated patients who had other problems dental they should do. ineligible for Byte processing. As a result, the defendants’ positive statements regarding Byte’s customer experience, and the expansive network of dentists who oversee and control each customer’s treatment, were materially misleading and/or lacked a reasonable basis. Furthermore, Dentsply Sirona concealed the fact that its high conversion rates were due to sales incentives to enroll contraindicated patients. When the real details entered the market, the lawsuit claims that investors suffered damages.

To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information about the class action.

No Class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the advice of your choice. You can also be an absent class member and do nothing at this point. The investor’s ability to share in any potential future recovery is not dependent on serving as the principal actor.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https :/ /www.facebook.com/rosenlawfirm/.

Attorney Advertising. Previous results do not guarantee a similar result.

——————————–

To view the source version of this press release, visit https://www.newsfilecorp.com/release/237618